Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives

by Zoltán Kaló, Zsuzsanna Ida Petykó, Frank-Ulrich Fricke, Nikos Maniadakis, Tomáš Tesař, Kateřina Podrazilová, Jaime Espin, András Inotai
Published 2021-07-01

Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings

by Zsuzsanna Ida Petykó, Zoltán Kaló, Jaime Espin, Kateřina Podrazilová, Tomáš Tesař, Nikos Maniadakis, Frank-Ulrich Fricke, András Inotai
Published 2021-08-01

Health economic evaluation of gene replacement therapies: methodological issues and recommendations

by Samuel Aballéa, Katia Thokagevistk, Rimma Velikanova, Steven Simoens, Lieven Annemans, Fernando Antonanzas, Pascal Auquier, Clément François, Frank-Ulrich Fricke, Daniel Malone, Aurélie Millier, Ulf Persson, Stavros Petrou, Omar Dabbous, Maarten Postma, Mondher Toumi
Published 2020-01-01